Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
Lenvatinib Plus PD-1 Antibody for Unresectable ICC
ClinicalTrials.gov study NCT03779100. IPD Sharing: Not stated. Countries: 1. Publications: 0.
N-803 and PD-L1 t-haNK Combined With Bevacizumab for Recurrent or Progressive Glioblastoma
ClinicalTrials.gov study NCT06061809. IPD Sharing: NO. Countries: 1. Publications: 0.
Influence of OATP1B1 and BRCP Genotype on Rosuvastatin PK, PD and Lipidomics in Hyperlipidemic Patients
ClinicalTrials.gov study NCT01466608. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Substudy 02A: Safety and Efficacy of Pembrolizumab in Combination With Investigational Agents in Participants With Programmed Cell-death 1 (PD-1) Refractory Melanoma (MK-3475-02A/KEYMAKER-U02)
ClinicalTrials.gov study NCT04305041. IPD Sharing: YES. Countries: 7. Publications: 0.
Study Of Three Different Stomach Acid Reducing Agents When Given With Palbociclib (PD-0332991) And Food
ClinicalTrials.gov study NCT02097329. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Effect of Low-frequency rTMS on Motor Function in PD Patients With Freezing of Gait
ClinicalTrials.gov study NCT02221544. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Safety and Preliminary Efficacy Evaluation of LC-K76 Plus Anti-PD-1 Therapy in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)
ClinicalTrials.gov study NCT07389187. IPD Sharing: NO. Countries: 1. Publications: 0.
Transarterial Neoadjuvant Chemotherapy vs.Traditional Intravenous Chemotherapy For Locally Advanced Gastric Cancer With SOX+PD-1
ClinicalTrials.gov study NCT05593458. IPD Sharing: NO. Countries: 1. Publications: 0.
This is a Phase 1, Randomized, Single-blind, Placebo-controlled Study to Assess the Safety, Pharmacokinetics (PK), and Pharmacodynamics (PD) of BEAM-103 in Healthy Subjects
ClinicalTrials.gov study NCT07304791. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Rimegepant Combined With PD-1 in Liver Metastasis Colorectal Cancer Patients
ClinicalTrials.gov study NCT06999252. IPD Sharing: NO. Countries: 1. Publications: 0.
An Ascending Dose Study to Evaluate M281 Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD)
ClinicalTrials.gov study NCT02828046. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Robotic Rehabilitation of Upper Limb in PD
ClinicalTrials.gov study NCT03893786. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Study on the Safety and Efficacy of Donafinib Combined With Anti-PD-1 Antibody as Adjuvant Therapy for HCC Patients
ClinicalTrials.gov study NCT04418401. IPD Sharing: NO. Countries: 1. Publications: 0.
CT-Guided Adaptive Radiation Therapy Combine With Anti-PD-1 Antibody Adjuvant Immunotherapy for Thoracic Cancer Patients
ClinicalTrials.gov study NCT03732430. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study of a PD-1/CTLA-4 Bispecific Antibody AK104 in Patients With Metastatic Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT04220307. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluation of PD-L1 (Programmed Death-Ligand 1) Tumor Expression in Patients With Large-cell Neuroendocrine Carcinoma (NEC)
ClinicalTrials.gov study NCT03305133. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Personalised Neoantigen-targeting Cancer Vaccine NECVAX-NEO1 in Anti-PD-1/PD-L1 Therapy in Patients With Solid Tumors
ClinicalTrials.gov study NCT06631079. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Study of PD-1 Antibody Combined With Chemoradiotherapy in Oligometastatic Esophageal Cancer
ClinicalTrials.gov study NCT04821765. IPD Sharing: NO. Countries: 1. Publications: 0.
Treating Muscle-invasive Bladder Cancer With A Non-surgical Method Consisting of Anti-PD-1 Therapy and Chemoradiation
ClinicalTrials.gov study NCT05975307. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Efficacy and Safety of the Bispecific Anti-PD-1/PD-L1 Antibody IBI318 Combined with Lenvatinib in NSCLC.
ClinicalTrials.gov study NCT04777084. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.